Farnum Rhonda 4
Research Summary
AI-generated summary
Theravance Biopharma (TBPH) SVP Rhonda Farnum Withholds 5,678 Shares
What Happened Rhonda Farnum, Senior Vice President, Commercial & Medical Affairs at Theravance Biopharma (TBPH), had 5,678 shares withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units. The withholding was recorded on 2026-05-20 at a price of $16.55 per share, totaling approximately $93,971. This was a tax-withholding disposition (code F), not an open-market sale.
Key Details
- Transaction date and price: 2026-05-20 at $16.55 per share.
- Shares withheld / disposed: 5,678 shares, value ≈ $93,971.
- Shares owned after transaction: Not specified in the provided filing summary.
- Footnote: F1 — shares were withheld by the issuer to cover taxes from RSU vesting; no open market transaction occurred.
- Filing timeliness: No late-filing indication provided in the supplied data.
Context This was a routine tax-withholding event following RSU vesting (cashless share withholding) rather than a sale executed in the market, so it should not be interpreted as a directional buy/sell signal. Tax-withholdings are common when equity awards vest and do not necessarily reflect the insider’s view on the company’s prospects.